Neuberger Berman Group LLC Frequency Therapeutics, Inc. Transaction History

Neuberger Berman Group LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.03 - $2.03 $23,139 - $45,605	-22,466 Reduced 52.9%	20,000 $30,000
Q1 2022 May 13, 2022	SELL	$1.7 - $5.72 $8 - $28	-5 Reduced 0.01%	42,466 $90,000
Q4 2021 Feb 11, 2022	SELL	$4.95 - $7.11 $65,983 - $94,776	-13,330 Reduced 23.89%	42,471 $218,000
Q3 2021 Nov 12, 2021	SELL	$6.96 - $9.25 $11,832 - $15,725	-1,700 Reduced 2.96%	55,801 $394,000
Q2 2021 Aug 13, 2021	BUY	$8.05 - $11.61 $14,433 - $20,816	1,793 Added 3.22%	57,501 $576,000
Q1 2021 May 13, 2021	SELL	$7.99 - $55.01 $3.03 Million - $20.8 Million	-378,806 Reduced 87.18%	55,708 $533,000
Q4 2020 Feb 10, 2021	BUY	$18.65 - $40.0 $626,695 - $1.34 Million	33,603 Added 8.38%	434,514 $15.3 Million
Q3 2020 Nov 12, 2020	BUY	$17.76 - $24.96 $6.2 Million - $8.71 Million	349,153 Added 674.59%	400,911 $7.7 Million
Q4 2019 Feb 12, 2020	BUY	$12.67 - $18.73 $655,773 - $969,427	51,758 New	51,758 $907,000

Ticker FREQ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,262,000
Description
Frequency Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapeutics to activate a person's innate regenerative potential to restore function. Its Progenitor Cell Activation approach uses small molecules and activate progenitor cells within the body to create functional tissue. The company's lead product candi...

Get notified when there are updates to the investment portfolio of Neuberger Berman Group LLC, based on Form 13F filings with the SEC.

Stay updated on Neuberger Berman Group LLC with notifications on news.